register

Medical and Science

RACGP warns of higher costs for patients needing ECGs

Health Industry Hub | July 27, 2020 |

Medical News: The Royal Australian College of General Practitioners (RACGP) is warning that patients who need electrocardiograms (ECGs) will likely face higher costs due to imminent changes to the Medicare Benefits Schedule (MBS).

The changes to MBS items for ECGs, due to come into force on August 1st, will significantly reduce patient rebates for ECGs in general practice, effectively restricting these services to consultant physicians and other specialists.

Under the changes, patients will only be eligible for item 11707 for ECG tracing in general practice, and will no longer be able to claim for tracing and reporting. This will result in a substantially lowered patient rebate.

RACGP President Dr Harry Nespolon said the changes would likely result in higher costs and inconvenience for patients.

“The RACGP is deeply disappointed at the decision to reduce patient rebates for ECGs in general practice – these changes are likely to hurt patients through higher costs and inconvenience.

“The decision completely fails to recognise the work GPs do with ECGs – we perform interpretation, report results in patient records and determine actions that need to be taken, very often without needing to refer patients to another specialist for interpretation and reporting.

“The changes mean patients will more likely have to go to more expensive specialists for these services and face higher out of pocket costs.

“The RACGP advocated strongly against these changes for good reason. Chronic conditions requiring ECGs and associated care like heart problems are increasing in Australia.

“Primary care is the most cost effective way of providing high-quality care for such patients – the government should be investing in primary care to keep patients out of the hospital system, instead we are seeing this ripped away.”


News & Trends - MedTech & Diagnostics

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms

Health Industry Hub | April 17, 2025 |

Hospitals shouldn’t be forced to grovel to private health insurers to secure funding for essential, lifesaving medical devices. But thanks […]

More


News & Trends - Pharmaceuticals

Oncologists pioneer liquid biopsy-guided treatment in lung cancer

Oncologists pioneer liquid biopsy-guided treatment in lung cancer

Health Industry Hub | April 17, 2025 |

Lung cancer is Australia’s leading cause of cancer deaths. Local experts are set to lead a new frontier in personalised […]

More


Medical and Science

The high cost of record low research funding

The high cost of record low research funding

Health Industry Hub | April 17, 2025 |

Australia has delivered some of the world’s most transformative health and medical breakthroughs – the cochlear implant, the HPV vaccine, […]

More


News & Trends - Pharmaceuticals

UCB secures dermatology indication with first dual IL-17A/F inhibitor

UCB secures dermatology indication with first dual IL-17A/F inhibitor

Health Industry Hub | April 17, 2025 |

UCB’s IL-17A and IL-17F inhibitor has been added to the Australian Register of Therapeutic Goods (ARTG) for adults with moderate […]

More


This content is copyright protected. Please subscribe to gain access.